These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

802 related articles for article (PubMed ID: 17365223)

  • 1. Test for the consistency of noninferiority from multiple clinical trials.
    Yan X; Wang MC; Su X
    J Biopharm Stat; 2007; 17(2):265-78. PubMed ID: 17365223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed noninferiority margin and statistical tests in active controlled trials.
    Tsou HH; Hsiao CF; Chow SC; Yue L; Xu Y; Lee S
    J Biopharm Stat; 2007; 17(2):339-57. PubMed ID: 17365228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous test for superiority and noninferiority hypotheses in active-controlled clinical trials.
    Tsong Y; Zhang J
    J Biopharm Stat; 2007; 17(2):247-57. PubMed ID: 17365221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New tests for null hypothesis of non unity ratio of proportions.
    Koti KM
    J Biopharm Stat; 2007; 17(2):229-45. PubMed ID: 17365220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the Fieller-Hinkley distribution of the ratio of random variables in testing for noninferiority.
    Koti KM
    J Biopharm Stat; 2007; 17(2):215-28. PubMed ID: 17365219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninferiority testing beyond simple two-sample comparison.
    Tsong Y; Chen WJ
    J Biopharm Stat; 2007; 17(2):289-308. PubMed ID: 17365225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choice of delta noninferiority margin and dependency of the noninferiority trials.
    Tsong Y; Zhang J; Levenson M
    J Biopharm Stat; 2007; 17(2):279-88. PubMed ID: 17365224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An alternative approach to assess exchangeability of a test treatment and the standard treatment with normally distributed response.
    Tsong Y; Shen M
    J Biopharm Stat; 2007; 17(2):329-38. PubMed ID: 17365227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Issues with statistical risks for testing methods in noninferiority trial without a placebo ARM.
    Hung HM; Wang SJ; O'Neill R
    J Biopharm Stat; 2007; 17(2):201-13. PubMed ID: 17365218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous testing of noninferiority and superiority increases the false discovery rate.
    Ng TH
    J Biopharm Stat; 2007; 17(2):259-64. PubMed ID: 17365222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Issues of simultaneous tests for noninferiority and superiority.
    Ng TH
    J Biopharm Stat; 2003 Nov; 13(4):629-39; discussion 641-62. PubMed ID: 14584713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decision-theoretic views on simultaneous testing of superiority and noninferiority.
    Koyama T; Westfall PH
    J Biopharm Stat; 2005; 15(6):943-55. PubMed ID: 16279353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the statistical power for multiple tests: a case study.
    Yeo A; Qu Y
    Pharm Stat; 2009; 8(1):5-11. PubMed ID: 18381588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the lower predictive bound approach for noninferiority clinical trials with binary data.
    Liu Q; Li Y
    J Biopharm Stat; 2014; 24(6):1225-38. PubMed ID: 25036815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated confidence intervals for adaptive group sequential trials.
    Mehta CR; Bauer P; Posch M; Brannath W
    Stat Med; 2007 Dec; 26(30):5422-33. PubMed ID: 17918195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple method for calculating power based on a prior trial.
    Borm GF; Bloem BR; Munneke M; Teerenstra S
    J Clin Epidemiol; 2010 Sep; 63(9):992-7. PubMed ID: 20573484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample size computation for two-sample noninferiority log-rank test.
    Jung SH; Kang SJ; McCall LM; Blumenstein B
    J Biopharm Stat; 2005; 15(6):969-79. PubMed ID: 16279355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Data-driven analysis strategies for proportion studies in adaptive group sequential test designs.
    Wassmer G
    J Biopharm Stat; 2003 Nov; 13(4):585-603. PubMed ID: 14584710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The adjustment of the type I error rate in noninferiority trials with λ-margin approach: each of two different new drugs is approved with two independent trials with the same active control.
    Kang SH; Ryu Y
    J Biopharm Stat; 2011 May; 21(3):498-510. PubMed ID: 21442522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A note on partial covariate-adjustment and design considerations in noninferiority trials when patient-level data are not available.
    Nie L; Soon GG; Qi K; Chen Y; Chu H
    J Biopharm Stat; 2013; 23(5):1042-53. PubMed ID: 23957514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.